Thrombohemolytic thrombocytopenic purpura during penicillamine therapy.
Penicillamine therapy was associated with the development of thrombohemolytic thrombocytopenic purpura (TTP) in a 23-year-old woman. The immunological and hematological toxicity of penicillamine, as well as the occurrence of TTP with parent penicillin compounds, indicates a probable etiological role of this drug.
D000328:Adult; D005260:Female; D006801:Humans; D010396:Penicillamine / Q000009:adverse effects*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced* / Q000473:pathology
D010396:Penicillamine